Lv3
288 积分 2024-03-29 加入
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems
1个月前
已完结
The Rationale for BAFF Inhibition in Systemic Lupus Erythematosus
2个月前
已完结
DB-2304, a Duality Immune Modulating Antibody‒Drug Conjugate (DIMAC) targeting BDCA2, displays strong potency in the suppression of pDC functions
2个月前
已完结
Nonclinical Development of Next-generation Site-specific HER2-targeting Antibody–drug Conjugate (ARX788) for Breast Cancer Treatment
5个月前
已完结
Drug-Linkers in Antibody–Drug Conjugates: Perspective on Current Industry Practices
6个月前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
6个月前
已完结
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
7个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
7个月前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
7个月前
已完结
皖公网安备34019202002308
